Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Dev Biol ; 419(2): 311-320, 2016 11 15.
Article in English | MEDLINE | ID: mdl-27609454

ABSTRACT

Fidelity of histone gene expression is important for normal cell growth and differentiation that is stringently controlled during development but is compromised during tumorigenesis. Efficient production of histones for packaging newly replicated DNA is particularly important for proper cell division and epigenetic control during the initial pre-implantation stages of embryonic development. Here, we addressed the unresolved question of when the machinery for histone gene transcription is activated in the developing zygote to accommodate temporal demands for histone gene expression. We examined induction of Histone Nuclear Factor P (HINFP), the only known transcription factor required for histone H4 gene expression, that binds directly to a unique H4 promoter-specific element to regulate histone H4 transcription. We show that Hinfp gene transcripts are stored in oocytes and maternally transmitted to the zygote. Transcripts from the paternal Hinfp gene, which reflect induction of zygotic gene expression, are apparent at the 4- to 8-cell stage, when most maternal mRNA pools are depleted. Loss of Hinfp expression due to gene ablation reduces cell numbers in E3.5 stage embryos and compromises implantation. Reduced cell proliferation is attributable to severe reduction in histone mRNA levels accompanied by reduced cell survival and genomic damage as measured by cleaved Caspase 3 and phospho-H2AX staining, respectively. We conclude that transmission of maternal Hinfp transcripts and zygotic activation of the Hinfp gene together are necessary to control H4 gene expression in early pre-implantation embryos in order to support normal embryonic development.


Subject(s)
Embryonic Development , Gene Expression Regulation, Developmental , Histones/biosynthesis , RNA, Messenger, Stored/genetics , Repressor Proteins/physiology , Zygote/metabolism , Animals , Blastocyst/physiology , Caspase 3/metabolism , Embryo Implantation/physiology , Embryonic Development/physiology , Female , Genes, Reporter , Histones/genetics , Histones/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Promoter Regions, Genetic , RNA, Messenger/metabolism , Repressor Proteins/deficiency , Repressor Proteins/genetics
2.
Cell Cycle ; 14(15): 2501-8, 2015 Aug 03.
Article in English | MEDLINE | ID: mdl-26030398

ABSTRACT

Histone Nuclear Factor P (HINFP) is essential for expression of histone H4 genes. Ablation of Hinfp and consequential depletion of histones alter nucleosome spacing and cause stalled replication and DNA damage that ultimately result in genomic instability. Faithful replication and packaging of newly replicated DNA are required for normal cell cycle control and proliferation. The tumor suppressor protein p53, the guardian of the genome, controls multiple cell cycle checkpoints and its loss leads to cellular transformation. Here we addressed whether the absence of p53 impacts the outcomes/consequences of Hinfp-mediated histone H4 deficiency. We examined mouse embryonic fibroblasts lacking both Hinfp and p53. Our data revealed that the reduced histone H4 expression caused by depletion of Hinfp persists when p53 is also inactivated. Loss of p53 enhanced the abnormalities in nuclear shape and size (i.e. multi-lobed irregularly shaped nuclei) caused by Hinfp depletion and also altered the sub-nuclear organization of Histone Locus Bodies (HLBs). In addition to the polyploid phenotype resulting from deletion of either p53 or Hinfp, inactivation of both p53 and Hinfp increased mitotic defects and generated chromosomal fragility and susceptibility to DNA damage. Thus, our study conclusively establishes that simultaneous loss of both Hinfp and the p53 checkpoint is detrimental to normal cell growth and may predispose to cellular transformation.


Subject(s)
Cell Cycle Checkpoints/genetics , DNA Damage/genetics , Histones/biosynthesis , Repressor Proteins/genetics , Tumor Suppressor Protein p53/genetics , Animals , Cell Line , Cell Proliferation/genetics , Cell Transformation, Neoplastic/genetics , Chromosome Fragility/genetics , DNA Replication/genetics , Fibroblasts/cytology , Genomic Instability/genetics , Histones/genetics , Mice , Mice, Knockout
3.
J Cell Physiol ; 230(11): 2683-94, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25808524

ABSTRACT

The Brahma (BRM) and Brahma-related Gene 1 (BRG1) ATPases are highly conserved homologs that catalyze the chromatin remodeling functions of the multi-subunit human SWI/SNF chromatin remodeling enzymes in a mutually exclusive manner. SWI/SNF enzyme subunits are mutated or missing in many cancer types, but are overexpressed without apparent mutation in other cancers. Here, we report that both BRG1 and BRM are overexpressed in most primary breast cancers independent of the tumor's receptor status. Knockdown of either ATPase in a triple negative breast cancer cell line reduced tumor formation in vivo and cell proliferation in vitro. Fewer cells in S phase and an extended cell cycle progression time were observed without any indication of apoptosis, senescence, or alterations in migration or attachment properties. Combined knockdown of BRM and BRG1 showed additive effects in the reduction of cell proliferation and time required for completion of cell cycle, suggesting that these enzymes promote cell cycle progression through independent mechanisms. Knockout of BRG1 or BRM using CRISPR/Cas9 technology resulted in the loss of viability, consistent with a requirement for both enzymes in triple negative breast cancer cells.


Subject(s)
Cell Proliferation/genetics , DNA Helicases/biosynthesis , Nuclear Proteins/biosynthesis , Transcription Factors/biosynthesis , Triple Negative Breast Neoplasms/genetics , Adenosine Triphosphatases/biosynthesis , Adenosine Triphosphatases/genetics , Animals , CRISPR-Cas Systems , Cell Cycle/genetics , Cell Line, Tumor , Cell Survival/genetics , Chromatin Assembly and Disassembly/genetics , DNA Helicases/genetics , Female , Gene Expression Regulation, Neoplastic , Gene Knockout Techniques , Humans , Mice , Nuclear Proteins/genetics , Transcription Factors/genetics , Triple Negative Breast Neoplasms/pathology
4.
Mol Cell Biol ; 34(14): 2650-9, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24797072

ABSTRACT

Fidelity of chromatin organization is crucial for normal cell cycle progression, and perturbations in packaging of DNA may predispose to transformation. Histone H4 protein is the most highly conserved chromatin protein, required for nucleosome assembly, with multiple histone H4 gene copies encoding identical protein. There is a long-standing recognition of the linkage of histone gene expression and DNA replication. A fundamental and unresolved question is the mechanism that couples histone biosynthesis with DNA replication and fidelity of cell cycle control. Here, we conditionally ablated the obligatory histone H4 transcription factor HINFP to cause depletion of histone H4 in mammalian cells. Deregulation of histone H4 results in catastrophic cellular and molecular defects that lead to genomic instability. Histone H4 depletion increases nucleosome spacing, impedes DNA synthesis, alters chromosome complement, and creates replicative stress. Our study provides functional evidence that the tight coupling between DNA replication and histone synthesis is reciprocal.


Subject(s)
DNA Replication , Genomic Instability , Histones/genetics , Repressor Proteins/genetics , Animals , Cell Cycle , Cell Line , Cell Proliferation , DNA Damage , Epigenesis, Genetic , Histones/metabolism , Mice , Mice, Knockout , Nucleosomes/metabolism
5.
Exp Hematol ; 41(11): 980-991.e1, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23823022

ABSTRACT

Definitive hematopoiesis requires the master hematopoietic transcription factor Runx1, which is a frequent target of leukemia-related chromosomal translocations. Several of the translocation-generated fusion proteins retain the DNA binding activity of Runx1, but lose subnuclear targeting and associated transactivation potential. Complete loss of these functions in vivo resembles Runx1 ablation, which causes embryonic lethality. We developed a knock-in mouse that expresses full-length Runx1 with a mutation in the subnuclear targeting cofactor interaction domain, Runx1(HTY350-352AAA). Mutant mice survive to adulthood, and hematopoietic stem cell emergence appears to be unaltered. However, defects are observed in multiple differentiated hematopoietic lineages at stages where Runx1 is known to play key roles. Thus, a germline mutation in Runx1 reveals uncoupling of its functions during developmental hematopoiesis from subsequent differentiation across multiple hematopoietic lineages in the adult. These findings indicate that subnuclear targeting and cofactor interactions with Runx1 are important in many compartments throughout hematopoietic differentiation.


Subject(s)
Cell Differentiation/genetics , Core Binding Factor Alpha 2 Subunit/genetics , Germ-Line Mutation , Hematopoiesis/genetics , Point Mutation , Animals , B-Lymphocytes/metabolism , Cell Proliferation , Cells, Cultured , Embryo, Mammalian/cytology , Embryo, Mammalian/embryology , Embryo, Mammalian/metabolism , Flow Cytometry , Gene Expression Regulation, Developmental , Hematopoietic Stem Cells/metabolism , Lymphopoiesis/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Fluorescence , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes/metabolism
6.
J Biol Chem ; 286(34): 30057-70, 2011 Aug 26.
Article in English | MEDLINE | ID: mdl-21676869

ABSTRACT

The Runt-related transcription factor, Runx2, is essential for osteogenesis and is controlled by both distal (P1) and proximal (P2) promoters. To understand Runx2 function requires determination of the spatiotemporal activity of P1 and P2 to Runx2 protein production. We generated a mouse model in which the P1-derived transcript was replaced with a lacZ reporter allele, resulting in loss of P1-derived protein while simultaneously allowing discrimination between the activities of the two promoters. Loss of P1-driven expression causes developmental defects with cleidocranial dysplasia-like syndromes that persist in the postnatal skeleton. P1 activity is robust in preosteogenic mesenchyme and at the onset of bone formation but decreases as bone matures. Homozygous Runx2-P1(lacZ/lacZ) mice have a normal life span but exhibit severe osteopenia and compromised bone repair in adult mice because of osteoblastic defects and not increased osteoclastic resorption. Gene expression profiles of bone, immunohistochemical studies, and ex vivo differentiation using calvarial osteoblasts and marrow stromal cells identified mechanisms for the skeletal phenotype. The findings indicate that P1 promoter activity is necessary for generating a threshold level of Runx2 protein to commit sufficient osteoprogenitor numbers for normal bone formation. P1 promoter function is not compensated via the P2 promoter. However, the P2 transcript with compensatory mechanisms from bone morphogenetic protein (BMP) and Wnt signaling is adequate for mineralization of the bone tissue that does form. We conclude that selective utilization of the P1 and P2 promoters enables the precise spatiotemporal expression of Runx2 necessary for normal skeletogenesis and the maintenance of bone mass in the adult.


Subject(s)
Calcification, Physiologic/physiology , Core Binding Factor Alpha 1 Subunit/biosynthesis , Gene Expression Regulation/physiology , Osteoblasts/metabolism , Osteogenesis/physiology , Promoter Regions, Genetic/physiology , Stem Cells/metabolism , Animals , Bone Diseases, Developmental/genetics , Bone Diseases, Developmental/metabolism , Bone Diseases, Metabolic/genetics , Bone Diseases, Metabolic/metabolism , Bone Regeneration/physiology , Core Binding Factor Alpha 1 Subunit/genetics , Mice , Mice, Transgenic
7.
Dev Biol ; 340(1): 10-21, 2010 Apr 01.
Article in English | MEDLINE | ID: mdl-20079730

ABSTRACT

MicroRNA attenuation of protein translation has emerged as an important regulator of mesenchymal cell differentiation into the osteoblast lineage. A compelling question is the extent to which miR biogenesis is obligatory for bone formation. Here we show conditional deletion of the Dicer enzyme in osteoprogenitors by Col1a1-Cre compromised fetal survival after E14.5. A mechanism was associated with the post-commitment stage of osteoblastogenesis, demonstrated by impaired ECM mineralization and reduced expression of mature osteoblast markers during differentiation of mesenchymal cells of ex vivo deleted Dicer(c/c). In contrast, in vivo excision of Dicer by Osteocalcin-Cre in mature osteoblasts generated a viable mouse with a perinatal phenotype of delayed bone mineralization which was resolved by 1 month. However, a second phenotype of significantly increased bone mass developed by 2 months, which continued up to 8 months in long bones and vertebrae, but not calvariae. Cortical bone width and trabecular thickness in Dicer(Deltaoc/Deltaoc) was twice that of Dicer(c/c) controls. Normal cell and tissue organization was observed. Expression of osteoblast and osteoclast markers demonstrated increased coupled activity of both cell types. We propose that Dicer generated miRs are essential for two periods of bone formation, to promote osteoblast differentiation before birth, and control bone accrual in the adult.


Subject(s)
Cell Differentiation , DEAD-box RNA Helicases/genetics , Endoribonucleases/genetics , Osteoblasts/metabolism , Osteogenesis/physiology , Stem Cells/cytology , Animals , Cellular Senescence , Collagen Type I/genetics , Collagen Type I/metabolism , Collagen Type I, alpha 1 Chain , DEAD-box RNA Helicases/metabolism , Embryo, Mammalian/metabolism , Endoribonucleases/metabolism , Genes, Lethal , Mice , Mice, Inbred Strains , RNA, Messenger/metabolism , Ribonuclease III , Stem Cells/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...